BridgeMD
New treatment option for Middle Cerebral Artery Aneurysm
Official title Middle Cerebral Artery Aneurysm Trial
ClinicalTrials.gov ID: NCT05161377
What this study is testing
- What it's testing
- Intracranial aneurysms located on the middle cerebral artery (MCA) are considered by many surgeons to represent a distinct subgroup of aneurysms for which clipping may still be the best management option. Most MCA aneurysms are accessible, proximal control can readily be secured in case of rupture, and clip application can typically proceed without requiring the dissection of perforating arteries.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients at least 18 years of age
- At least one documented, intradural, intracranial aneurysm anywhere on the course of the MCA vessel, ruptured or unruptured. An untreated ruptured...
- In the case of SAH, WFNS grade 4 or less
- The patient and aneurysm are considered appropriate for either surgical or endovascular treatment by the treating team
You likely can't join if
- Patients with absolute contraindications administration of contrast material (any type)
- Patients with AVM-associated aneurysms
- Patients or caregivers unable to provide consent
- Poor grade (WFNS 5) ruptured aneurysms
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.